# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-19-000303
Filing Date
2019-07-12
Accepted
2019-07-12 17:06:13
Documents
16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 1886171
2 |  | g114644.jpg | GRAPHIC | 98928
3 |  | g142480.jpg | GRAPHIC | 119210
4 |  | g416205.jpg | GRAPHIC | 35324
5 |  | g438810.jpg | GRAPHIC | 42584
6 |  | g453739.jpg | GRAPHIC | 20890
7 |  | g501588.jpg | GRAPHIC | 37620
8 |  | g504981.jpg | GRAPHIC | 88585
9 |  | g584941.jpg | GRAPHIC | 35709
10 |  | g602177.jpg | GRAPHIC | 86178
11 |  | g701865.jpg | GRAPHIC | 96160
12 |  | g731568.jpg | GRAPHIC | 83509
13 |  | g785591.jpg | GRAPHIC | 74940
14 |  | g817326.jpg | GRAPHIC | 30086
15 |  | g849095.jpg | GRAPHIC | 43010
16 |  | g1043123.jpg | GRAPHIC | 63175
| Complete submission text file | 0000912057-19-000303.txt |  | 3203973

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02729 | Film No.: 19953516
SIC: 2834 Pharmaceutical Preparations